前列地尔注射液治疗肺动脉高压的疗效分析  

Analysis of Effect of Prostaglandin E1 in Treatment of Pulmonary Hypertension

作　　者：熊海刚[1] 陈振云[1] 张思思[1] 

机构地区：[1]解放军第113医院心内科,浙江宁波315040

出　　处：《临床医学工程》2011年第10期1581-1582,共2页Clinical Medicine & Engineering

摘　　要：目的探讨前列地尔注射液(凯时)治疗肺动脉高压的疗效。方法肺动脉高压患者随机分为两组,一组常规治疗及硝苯地平口服,一组在上述基础上予以前列地尔注射液(凯时)静脉点滴,对比两组治疗前后肺动脉高压的变化。结果两组均能有效降低肺动脉压,但前列地尔注射液组能显著降低肺动脉高压,与治疗前比较,P<0.05。结论常规治疗及硝苯地平口服基础上予以前列地尔注射液(凯时)静脉点滴,能显著降低患者肺动脉高压,改善患者临床症状。Objective To observe the effect of prostaglandin E1 in treatment of pulmonary hypertension. Methods Patients with pulmonary hypertension were divded into two groups randomly, one group were given routine treatment and nifedipine orally, another group plus prostaglandin E1 intravenous drip, to compare the changes of pulmonary hypertension before and after treatment. Results The two groups counld decrease pulmonary hypertension effectly, but prostaglandin E1 counld remarkablely decrease pulmonary hypertension with significantly comparative difference （P 0.05）. Conclusion Prostaglandin E1 intravenous drip on the basis of routine treatment and oral nifedipine counld remarkablely decrease pulmonary hypertension, and improve the clinic symptoms of patients.

关 键 词：前列地尔 肺动脉高压 

分 类 号：R543.2[医药卫生—心血管疾病]